1015 Capital Partners’s Hologic HOLX Stock Holding History

1015 Capital Partners’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8	Closed	-$605	–	618
2026 Q1	$605	Hold	8	–	–	﹤0.01%	510
2025 Q4	$596	Buy	+8	New	+$585	﹤0.01%	532

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

1015 Capital Partners's HOLX Position: Q2 2026 in Review

1015 Capital Partners sold out of Hologic (HOLX) in Q2 2026, closing a stake of 8 shares — an estimated $605 sold.

1015 Capital Partners first reported a position in HOLX in Q4 2025 and held it in 2 quarters. The position peaked at $605 in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

1015 Capital Partners reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
1015 Capital Partners sold 8 Hologic shares in Q2 2026, an estimated $605.
1015 Capital Partners first reported a position in Hologic in Q4 2025 and held it in 2 quarters.
1015 Capital Partners's Hologic position peaked at $605 in Q1 2026.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.